The question worth asking first
A man with low energy in St. Pete has plenty of options. The question worth asking any of them is what has to happen before treatment starts: the confirmatory second draw, the pituitary hormones that explain why a level is low, and the screening that catches the man who shouldn't be on testosterone at all.
The distinction we'd put in front of you is structural. Ascend is a board-certified family medicine practice, and the TRT program lives inside primary care where your thyroid, your sleep, your mood, and your blood pressure are all part of the same chart. When hormone therapy competes with that context, the context wins.
The question a careful patient asks isn't whether a treatment can make him feel different. It's whether anyone confirmed what was actually wrong first, and who is watching the bloodwork in year two.
Diagnostic honesty, spelled out
Every claim on this page reduces to one policy: lab-confirmed clinical hypogonadism is the entry criterion for treatment. Symptoms start the conversation, but symptoms alone never finish it, because fatigue and low mood have a long list of authors and testosterone is only one of them.
Confirming the diagnosis takes two mornings. Testosterone peaks early in the day, so draws happen between 7 and 10 a.m., and a single low value gets repeated on a different morning before it counts. That two-draw gate is standard practice here before any prescription decision, and it's the single clearest line between a medical workup and a sales funnel. If the second draw comes back normal, you'll hear that, along with what we'd investigate next. A no, or a not yet, is a real outcome of this evaluation, and it costs you a lot less than years on an unnecessary controlled medication.
The complaints that bring men in deserve a word too, because the marketing treats them as proof. Flagging energy, a duller mood, strength and body composition sliding despite consistent effort: all of it is worth investigating, and none of it is specific to testosterone. Sleep debt produces the same picture. So do thyroid problems, certain medications, alcohol, and untreated sleep apnea. Which is exactly why the panel casts a wide net instead of measuring one hormone and declaring victory.
A first visit that behaves like family medicine
Plan on about 45 minutes for the initial evaluation, in person or by Florida telehealth. That length isn't padding; it's what a genuine history takes when the differential is this wide. Dr. Saylor walks through your symptom story and the lifestyle inputs that move hormone numbers: sleep quality, training load, alcohol, current medications, and stress. A focused exam follows, then the lab order. You leave with a plan for two specific draw mornings instead of a prescription decided in advance of the evidence. The panel covers total testosterone and free testosterone plus SHBG, LH, FSH, estradiol, prolactin, a CBC, a comprehensive metabolic panel, lipids, HbA1c, TSH, and PSA when age-appropriate.
The convenient part for St. Pete patients: the order goes wherever you want it. Quest and LabCorp both operate collection sites throughout the city, so both draw mornings happen near home or work, on your way to the office. LH and FSH matter because they separate a testicular problem from a signaling problem. Prolactin and TSH matter because they flag look-alike conditions. A cheap panel that checks one number can't do any of that.
A controlled medication gets a controlled process
Federal law classifies testosterone as Schedule III, the same controlled-substance framework that governs how it can be prescribed and monitored, and Ascend's process is built around that fact rather than around it. We prescribe testosterone only after a documented evaluation and a completed lab workup, and every prescription comes with required follow-up and monitoring attached. That's also why every plan starts with labs, whether the first visit is in person or by video.
From there, the geometry works in your favor. Patients can handle the first visit and routine follow-ups through Florida telehealth, with bloodwork drawn locally in St. Pete and reviewed on a schedule: a recheck at three months, another at six, then every six to twelve months for as long as therapy continues, in line with Endocrine Society guidance. Physician-led monitoring is the product you're actually buying; the vial is the cheap part.
What being an established patient actually looks like
Picture the second year of therapy for a man in the Old Northeast. His lab order arrives ahead of each scheduled recheck. He stops at whichever collection site suits his morning, and a few days later he takes the follow-up visit as a video call, results already in front of the physician who ordered them. Dose holding steady, numbers behaving, done. When something drifts, the plan changes on that call and the next round of bloodwork verifies the fix.
Nothing about that routine requires an in-person appointment, though the offices are there if you want one. The controlled-substance rules get honored where they matter, at the start and in the monitoring, while the recurring burden on your calendar shrinks to lab mornings and video visits. Men who travel for work tend to appreciate that the model bends around a schedule instead of demanding one.
If the labs confirm it: options, trade-offs, and the fertility talk
Once clinical hypogonadism is confirmed, treatment is a menu, not a mandate. Injectable testosterone cypionate or enanthate, given intramuscularly or subcutaneously on a weekly or twice-weekly rhythm, sits alongside topical gel and pellets. Frequency, side-effect profile, cost, and fertility impact differ across routes, and the best fit depends on your needle tolerance, travel, and family plans rather than on any universal ranking.
The fertility conversation happens before the prescription, not after. Exogenous testosterone suppresses LH and FSH, and sperm production drops with them, often substantially. Men who still want children should hear about the alternatives that preserve sperm production instead of suppressing it, and at Ascend they do. That conversation changes decisions often enough to justify its place at the front of the process rather than as a footnote on a consent form.
As for what therapy will feel like: many men with confirmed low levels do meaningfully better on treatment, responses vary man to man, and no one can guarantee you an outcome. Possible side effects are real too, including increased red blood cell count, fertility suppression, and worsening of sleep apnea, which is why the monitoring calendar isn't optional and why "set it and forget it" is not a phrase you'll hear in this program.
Fatigue has many authors
Some portion of the men who book this evaluation don't have a testosterone problem, and finding that out is a win, not a wasted visit. Thyroid dysfunction produces fatigue, mood changes, and body-composition complaints that get pinned on low T constantly, which is why TSH ships with the panel. Untreated sleep apnea drags testosterone down and needs its own attention. Depression and hormone health overlap enough that our psychiatric team gets looped in when both are in play. Chronic pain saps activity and energy in ways that read as hormonal. And carrying extra visceral fat lowers testosterone, so medical weight loss is sometimes the lever that actually moves the numbers.
This program belongs to Ascend's men's health pillar, where TRT, preventive screening, and chronic disease management share one roof, and it's led by a physician built for that breadth: Dr. Jason Saylor, DO, board-certified in osteopathic family medicine, 17 years in practice, Chief Medical Officer at Ascend, with a clinical scope covering men's health, hormone evaluation, weight loss management, preventive medicine, and chronic disease management. He sees St. Petersburg men in person at the offices or by Florida telehealth from the first visit, which means the person adjusting your dose in month nine is the same one who took your history on day one.
That continuity is the underrated value of a medical practice. Your story stays in one chart, in front of one physician, visit after visit, and the hormone decision keeps getting made against the whole of it.
Estradiol, and the myth that lower is always better
Men are frequently told that estrogen is the enemy of testosterone therapy and that the goal is to drive it as low as possible. That belief is popular, profitable for anyone selling a blocker alongside the hormone, and wrong. A portion of testosterone is converted to estradiol by design, and men need estradiol. It contributes to bone density, to lipid handling, to libido, and to mood. Crushing it produces its own recognizable misery: aching joints, flattened sex drive, low mood, and over years, weaker bone.
Estradiol is on the panel for a reason, but the number gets read in context rather than chased toward zero. A genuinely elevated result in a man with matching symptoms is worth acting on, and the first move is almost always to reduce or split the testosterone dose rather than to add a second medication. Body fat matters here too, because adipose tissue is where much of the conversion happens, which is one of several reasons weight and metabolic health are part of this conversation rather than a separate appointment.
A blocker is a real medication with real consequences and it is not part of the standard opening plan. Where one is genuinely indicated, it comes with its own monitoring and its own honest discussion of trade-offs. The general rule we work from: treat the man, not the printout, and be suspicious of any protocol that hands out a second prescription to manage the side effects of the first one before anyone has checked whether the first one was dosed correctly.
Coverage, and what happens next
On money: benefits get verified before any prescription decision, and Dr. Saylor currently participates in-network with Aetna, ChampVA, TRICARE East, and UnitedHealthcare, with lab work generally covered. Self-pay works too, priced by visit type and labs ordered rather than a flat sheet, and the billing team quotes exact rates when you call (813) 670-3331. No surprise bills is a stated policy here, not a slogan, and the way you get there is by settling the coverage question before the clinical one.
We serve the St. Petersburg core across 33701 through 33707, from downtown and the Old Northeast through Snell Isle, Allendale, Bartlett Park, and Greater Pinellas Point, and Pinellas neighbors closer to Clearwater have their own page. New TRT patients are typically seen within one to two weeks; calling (813) 670-3331 first thing in the morning or booking online gets you the earliest slot.
St. Petersburg ZIPs & nearby areas we serve
- St. Petersburg core: 33701-33707 (downtown, Old Northeast, Snell Isle, Allendale, Bartlett Park, Greater Pinellas Point)
- Clearwater: 33755-33763 - see TRT in Clearwater
- Tampa proper: Carrollwood, South Tampa, Westchase - see TRT in Tampa
Comparing options before you choose? Our guide to TRT clinics in Florida lays out how clinics handle labs, visits, insurance and payment.
FAQs about TRT in St. Petersburg
Where do St. Petersburg men go for TRT with Ascend?
Ascend has no St. Petersburg office. The evaluation can happen in person at our Tampa-Carrollwood office, 3971 Moran Road, Suite 101, Tampa, FL 33618, or at our Wesley Chapel flagship, 27724 Cashford Circle, Suite 102, Wesley Chapel, FL 33544, or by Florida telehealth. Every visit, the first evaluation included, can be by Florida telehealth for patients across 33701-33707, with labs drawn at a local lab near you. Testosterone is a controlled medication (Schedule III); we prescribe it only after a documented evaluation and lab workup, with required follow-up and monitoring.
What labs are involved in a TRT workup?
Morning total testosterone, free testosterone, SHBG, LH, FSH, estradiol, prolactin, CBC, comprehensive metabolic panel, lipid panel, HbA1c, TSH, and PSA when age-appropriate. Two confirmatory draws standard before any prescription.
How fast can a St. Pete patient get a TRT consult?
Most new TRT patients are seen within one to two weeks. Same-week appointments happen when slots open. Call (813) 670-3331 first thing in the morning.
Will TRT affect my fertility?
Yes, often substantially. Exogenous testosterone suppresses LH and FSH, which suppresses sperm production. If fertility is on your radar, we discuss it before any TRT decision.
Do you take insurance for TRT?
In-network with Aetna, ChampVA, TRICARE East, and UnitedHealthcare today. Lab work generally covered. We verify benefits before any prescription decisions.
TRT is a prescription medication for clinically diagnosed hypogonadism and requires lab confirmation, prescriber supervision, and ongoing monitoring. Possible side effects include increased red blood cell count, fertility suppression, sleep apnea worsening, and other clinically significant effects. Individual results vary. This page is informational and does not substitute for a clinical visit. Bhasin S et al. "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2018;103(5):1715-1744. See also FDA prescribing information for testosterone products via FDA Drugs@FDA.